1-2 of 2
Gavin WILLIS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in Type II diabetes

Available to Purchase
Mike J. Sampson, Simon Braschi, Gavin Willis, Sian B. Astley
Journal: Clinical Science
Clin Sci (Lond) (2005) 109 (2): 189–197.
https://doi.org/10.1042/CS20050089
Published: 25 July 2005
View article titled, Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in Type II diabetes
Open the PDF for Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in Type II diabetes in another window
Articles

Increased DNA oxidative susceptibility without increased plasma LDL oxidizability in Type II diabetes: effects of α-tocopherol supplementation

Available to Purchase
Michael J. SAMPSON, Sian ASTLEY, Tristan RICHARDSON, Gavin WILLIS, Isabel R. DAVIES, David A. HUGHES, Sue SOUTHON
Journal: Clinical Science
Clin Sci (Lond) (2001) 101 (3): 235–241.
https://doi.org/10.1042/cs1010235
Published: 03 August 2001
View article titled, Increased DNA oxidative susceptibility without increased plasma LDL oxidizability in Type II diabetes: effects of α-tocopherol supplementation
Open the PDF for Increased DNA oxidative susceptibility without increased plasma LDL oxidizability in Type II diabetes: effects of α-tocopherol supplementation in another window